Macrophages modulate engineered human tissues for enhanced vascularization and healing.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Immunology

Background:

• Tissue engineering aims to replicate human physiology but faces challenges in vascularization and controlling host inflammatory responses post-implantation.
• Functional vasculature is critical for engineered tissue survival and function in vivo.
• The inflammatory response, mediated by macrophages and cytokines, significantly influences vascularization and tissue outcomes.

Purpose of the Study:

• To explore cell-scaffold-bioreactor systems for leveraging the inflammatory response to improve tissue vascularization and healing.
• To discuss the transition from inert scaffolds to advanced "smart" tissue engineering systems.

Main Methods:

• Review and discussion of cell-scaffold-bioreactor systems in tissue engineering.
• Analysis of the role of inflammatory factors and macrophages in engineered tissue vascularization.
• Comparison of traditional inert scaffolds with next-generation "smart" systems.

Main Results:

• The inflammatory response is a key regulator of vascularization and engineered tissue functionality.
• "Smart" tissue engineering systems are emerging to actively manage tissue survival and function.
• Harnessing inflammatory pathways offers a promising strategy for enhanced tissue regeneration.

Conclusions:

• Effective control of inflammation and vascularization is crucial for successful tissue engineering.
• Advanced "smart" biomaterials and systems are replacing inert scaffolds to actively promote tissue integration and function.
• Future tissue engineering strategies should focus on modulating the host immune response for optimal therapeutic outcomes.